It should go without saying given the Texas Medical Board’s recent aggressive regulatory stance on the treatment of chronic pain, Texas physicians involved in the practice of testosterone and hormone replacement therapy should be made aware of a discussion by the Board at a recent Board meeting regarding a U.S. Food and Drug Association
Latest Post
More Posts
Texas Dental Board Offers Proposed Order Without Giving Dentists a Full Opportunity to Respond
An Overview of the Physician Peer Review Process and the Importance of Legal Counsel
Foreign Medical Graduates and the H-1B Visa: A Better Choice
The National Resident Matching Program and Common Problems to Avoid
Possible Secondary Effects of a Temporary Suspension on a Physician’s Medicare Billing Privileges and DEA Controlled Substances Registration
The Ryan Haight Act and the Changing Face of Telemedicine
Governor Rick Perry Makes Eight Appointments to Texas Medical Board
83rd Texas Legislature Makes Important Changes to Law Governing Without Notice Payment Holds on Medicaid Reimbursements
Important Update for Texas Nurses on a Board Order: Texas Board of Nursing Starts Screening for EtG and EtS
Subscribe: Subscribe via RSS
Firm/Org